Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Gomeni

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 4, 2011
Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depressionRoberto Gomeni, Emilio Merlo-Pich
Clinical and Translational Science|September 3, 2025
AI-NLME: A New Artificial Intelligence-Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo-Controlled Clinical TrialsRoberto Gomeni, Françoise Bressolle-Gomeni
Journal of Clinical Pharmacology|February 19, 2021
Modeling Complex Pharmacokinetics of Long-Acting Injectable Products Using Convolution-Based Models With Nonparametric Input FunctionsRoberto Gomeni, Françoise Bressolle-Gomeni
The AAPS Journal|December 11, 2019
Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric ApproachesRoberto Gomeni, Françoise Bressolle-Gomeni
Pharmaceutical Research|February 12, 2002
In silico prediction of optimal in vivo delivery properties using convolution-based model and clinical trial simulationRoberto Gomeni, Carla Dangeli, Alan Bye
Nuclear Medicine and Biology|January 12, 2002
Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approachStefano Zamuner, Roberto Gomeni, Alan Bye
Expert Opinion on Drug Discovery|March 19, 2013
Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunityGianluca Nucci, Roberto Gomeni, Italo Poggesi
Journal of Clinical Pharmacology|May 10, 2014
Does short-term placebo response predict the long-term observation? Meta-analysis on forced expiratory volume in 1 second from asthma trialsShuying Yang, Roberto Gomeni, Misba Beerahee
Journal of Clinical Pharmacology|January 27, 2018
Is It Time for Going Beyond the P-Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive DisorderRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
Modelling placebo response in depression trials using a longitudinal model with informative dropoutRoberto Gomeni, Agnes Lavergne, Emilio Merlo-Pich
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 4, 2011
Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depressionRoberto Gomeni, Emilio Merlo-Pich
Clinical and Translational Science|September 3, 2025
AI-NLME: A New Artificial Intelligence-Driven Nonlinear Mixed Effect Modeling Approach for Analyzing Longitudinal Data in Randomized Placebo-Controlled Clinical TrialsRoberto Gomeni, Françoise Bressolle-Gomeni
Journal of Clinical Pharmacology|February 19, 2021
Modeling Complex Pharmacokinetics of Long-Acting Injectable Products Using Convolution-Based Models With Nonparametric Input FunctionsRoberto Gomeni, Françoise Bressolle-Gomeni
The AAPS Journal|December 11, 2019
Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric ApproachesRoberto Gomeni, Françoise Bressolle-Gomeni
Pharmaceutical Research|February 12, 2002
In silico prediction of optimal in vivo delivery properties using convolution-based model and clinical trial simulationRoberto Gomeni, Carla Dangeli, Alan Bye
Nuclear Medicine and Biology|January 12, 2002
Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approachStefano Zamuner, Roberto Gomeni, Alan Bye
Expert Opinion on Drug Discovery|March 19, 2013
Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunityGianluca Nucci, Roberto Gomeni, Italo Poggesi
Journal of Clinical Pharmacology|May 10, 2014
Does short-term placebo response predict the long-term observation? Meta-analysis on forced expiratory volume in 1 second from asthma trialsShuying Yang, Roberto Gomeni, Misba Beerahee
Journal of Clinical Pharmacology|January 27, 2018
Is It Time for Going Beyond the P-Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive DisorderRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
Modelling placebo response in depression trials using a longitudinal model with informative dropoutRoberto Gomeni, Agnes Lavergne, Emilio Merlo-Pich
Pageof 8